38.85 0.39(1.00%)07/05/2024
Glaxosmithkline plc (GSK)
Glaxosmithkline plc (GSK)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| Will GSK Stock Rebound To Its 2022 Highs Of $47? | 07/05 09:00 | forbes.com |
| GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac | 07/04 10:46 | zacks.com |
| GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines | 07/03 13:46 | investopedia.com |
| GSK Will Pay Up to $1.5 Billion for CureVac's mRNA Vaccines | 07/03 10:18 | barrons.com |
| GSK Secures mRNA Vaccines For Bird Flu, COVID And Seasonal Flu From Struggling Biotech CureVac | 07/03 07:59 | forbes.com |
| CureVac's stock soars on GSK's $1.56 billion deal for its COVID-19 and flu vaccines | 07/03 07:53 | marketwatch.com |
| 3 No-Brainer Stocks to Buy With $300 Right Now for the Second Half of 2024 | 07/03 05:21 | fool.com |
| GSK takes full control of flu vaccine programme in €1.45bn deal | 07/03 03:11 | proactiveinvestors.co.uk |
| GSK and CureVac to Restructure Collaboration into New Licensing Agreement | 07/03 02:40 | accesswire.com |
| GSK buys full rights to make COVID, influenza vaccines from CureVac | 07/03 02:26 | reuters.com |